"Applicable Labs": The Fly in the PAMA Market-Based Pricing Ointment

Email not displaying correctly? View it in your browser.

Oct 24, 2017

MEDICARE COVERAGE
"Applicable Labs": The Fly in the PAMA Market-Based Pricing Ointment
From - Laboratory Industry Report
The lab industry has no objection to basing Medicare payments for lab tests on the actual rates charged to payors in the private market. What has the industry so upset is how…
Read More

		ANTI-KICKBACK Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry From - G2 Compliance Advisor Case: A urinalysis lab with a shady past figures prominently in an equally shady scheme involving TennCare, Tennessee's Medicaid program. According to… Read More

MEDICARE COVERAGE
Medicare Reimbursements: Part B Lab Payments Slightly Down for 2016, Reports OIG
From - National Intelligence Report
The OIG released its report on Medicare Part B payments for lab tests in 2016. The punchline: Lab payments over the past three years remain incredibly consistent in terms of…
Read More

INDUSTRY TRENDS
Diagnostics Industry Responding to Opioid Epidemic
From - Diagnostic Testing & Emerging Technologies
Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Unsubscribe | Forward to a Friend